CoChat
Sign Up
Cited by 136

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Evolving immunosuppressive microenvironment during human cervical carcinogenesis

Kobayashi, A, Weinberg, V, Darragh, T, Smith-McCune, K·2008·Mucosal Immunology
DOI 10.1038/mi.2008.33
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mi.2008.33

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 43

  1. Melnikow, 1998, Natural history of cervical squamous intraepithelial lesions: a meta-analysis, Obstet. Gynecol, 92,, 727
  2. Moscicki, 2004, Regression of low-grade squamous intra-epithelial lesions in young women, Lancet, 364,, 1678, 10.1016/S0140-6736(04)17354-6 · DOI
  3. Ostor, 1993, Natural history of cervical intraepithelial neoplasia: a critical review, Int. J. Gynecol. Pathol, 12,, 186, 10.1097/00004347-199304000-00018 · DOI
  4. Munoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N. Engl. J. Med, 348,, 518, 10.1056/NEJMoa021641 · DOI · Paper page
  5. Coleman, 1994, Immunological events in regressing genital warts, Am. J. Clin. Pathol, 102,, 768, 10.1093/ajcp/102.6.768 · DOI
  6. Tyring, 1998, Immune response modification: imiquimod, Australas. J. Dermatol, 39, S11
  7. Balkwill, 2004, Cancer: an inflammatory link, Nature, 431,, 405, 10.1038/431405a · DOI
  8. Lewis, 2006, Distinct role of macrophages in different tumor microenvironments, Cancer Res, 66,, 605, 10.1158/0008-5472.CAN-05-4005 · DOI · Paper page
  9. Pollard, 2004, Tumour-educated macrophages promote tumour progression and metastasis, Nat. Rev. Cancer, 4,, 71, 10.1038/nrc1256 · DOI
  10. Mantovani, 2006, Role of tumor-associated macrophages in tumor progression and invasion, Cancer Metastasis Rev, 25,, 315, 10.1007/s10555-006-9001-7 · DOI
  11. Pinzon-Charry, 2005, Dendritic cell dysfunction in cancer: a mechanism for immunosuppression, Immunol. Cell Biol, 83,, 451, 10.1111/j.1440-1711.2005.01371.x · DOI
  12. Zou, 2005, Immunosuppressive networks in the tumour environment and their therapeutic relevance, Nat. Rev. Cancer, 5,, 263, 10.1038/nrc1586 · DOI · Paper page
  13. Wakkach, 2003, Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo, Immunity, 18,, 605, 10.1016/S1074-7613(03)00113-4 · DOI
  14. Hwu, 2000, Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation, J. Immunol, 164,, 3596, 10.4049/jimmunol.164.7.3596 · DOI
  15. Mellor, 2003, Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion, J. Immunol, 171,, 1652, 10.4049/jimmunol.171.4.1652 · DOI
  16. Sakaguchi, 2001, Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance, Immunol. Rev, 182,, 18, 10.1034/j.1600-065X.2001.1820102.x · DOI
  17. Latchman, 2004, PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells, Proc. Natl. Acad. Sci. USA, 101,, 10691, 10.1073/pnas.0307252101 · DOI
  18. Zhang, 2006, Regulation of T cell activation and tolerance by PDL2, Proc. Natl. Acad. Sci. USA, 103,, 11695, 10.1073/pnas.0601347103 · DOI
  19. Daniel, 1997, The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions, J. Gen. Virol, 78, 1095, 10.1099/0022-1317-78-5-1095 · DOI
  20. Durst, 1992, Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization, Virology, 189,, 132, 10.1016/0042-6822(92)90688-L · DOI
  21. Stoler, 1992, Human papillomavirus type 16 and 18 gene expression in cervical neoplasias, Hum. Pathol, 23,, 117, 10.1016/0046-8177(92)90232-R · DOI
  22. Kobayashi, 2004, Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection, Cancer Res, 64,, 6766, 10.1158/0008-5472.CAN-04-1091 · DOI
  23. Kai, 2004, Indoleamine 2,3-dioxygenase is necessary for cytolytic activity of natural killer cells, Scand. J. Immunol, 59,, 177, 10.1111/j.0300-9475.2004.01378.x · DOI
  24. Nakamura, 2007, Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer, Cancer Sci, 98,, 874, 10.1111/j.1349-7006.2007.00470.x · DOI
  25. Sawitzki, 2005, IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo, J. Exp. Med, 201,, 1925, 10.1084/jem.20050419 · DOI
  26. Kim, 2006, Tumor-driven evolution of immunosuppressive networks during malignant progression, Cancer Res, 66,, 5527, 10.1158/0008-5472.CAN-05-4128 · DOI
  27. Geissmann, 1999, TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells, J. Immunol, 162,, 4567, 10.4049/jimmunol.162.8.4567 · DOI
  28. Gad, 2003, Dendritic cells in peripheral tolerance and immunity, APMIS, 111,, 766, 10.1034/j.1600-0463.2003.11107808.x · DOI
  29. Jonuleit, 2000, Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells, J. Exp. Med, 192,, 1213, 10.1084/jem.192.9.1213 · DOI
  30. Giannini, 1998, Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression, Clin. Exp. Immunol, 113,, 183, 10.1046/j.1365-2249.1998.00639.x · DOI
  31. Hammes, 2007, Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression—clinicopathological correlation, Gynecol. Oncol, 105,, 157, 10.1016/j.ygyno.2006.11.023 · DOI · Paper page
  32. al-Saleh, 1995, Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix, Virchows Arch, 427,, 41, 10.1007/BF00203736 · DOI
  33. Hachisuga, 1989, Immunohistochemical demonstration of histiocytes in normal ectocervical epithelium and epithelial lesions of the uterine cervix, Gynecol. Oncol, 33,, 273, 10.1016/0090-8258(89)90511-8 · DOI
  34. Tay, 1987, Tissue macrophage response in human papillomavirus infection and cervical intraepithelial neoplasia, Br. J. Obstet. Gynaecol, 94,, 1094, 10.1111/j.1471-0528.1987.tb02296.x · DOI
  35. Giraudo, 2004, An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis, J. Clin. Invest, 114,, 623, 10.1172/JCI200422087 · DOI · Paper page
  36. Smith-McCune, 1994, Demonstration and characterization of the angiogenic properties of cervical dysplasia, Cancer Res, 54,, 800
  37. Ressing, 2000, Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma, J. Immunother, 23,, 255, 10.1097/00002371-200003000-00010 · DOI
  38. Clerici, 1997, Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection, J. Natl. Cancer Inst, 89,, 245, 10.1093/jnci/89.3.245 · DOI
  39. El-Sherif, 2001, Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer, J. Pathol, 195,, 179, 10.1002/path.929 · DOI
  40. Dunn, 2004, The immunobiology of cancer immunosurveillance and immunoediting, Immunity, 21,, 137, 10.1016/j.immuni.2004.07.017 · DOI
  41. Kim, 2007, Cancer immunoediting from immune surveillance to immune escape, Immunology, 121,, 1, 10.1111/j.1365-2567.2007.02587.x · DOI
  42. Song, 2008, Interferon-gamma (IFN-gamma): a possible prognostic marker for clearance of high-risk human papillomavirus (HPV), Gynecol. Oncol, 108,, 543, 10.1016/j.ygyno.2007.11.006 · DOI
  43. Palefsky, 1998, Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men, J. Infect. Dis, 177,, 361, 10.1086/514194 · DOI

Cited by

See all 136

Metadata

Authors
Kobayashi, A., Weinberg, V, Darragh, T., & Smith-McCune, K.
Venue
Mucosal Immunology
Publisher
Elsevier BV
Published
2008-09
Volume
1
Issue
5
Pages
412-420
ISSN
1933-0219
DOI
10.1038/mi.2008.33
Cited by
136
References
5
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evolving immunosuppressive microenvironment during human cervical carcinogenesis. https://app.cochat.ai/papers/10.1038/mi.2008.33
The paper
Kobayashi, A., Weinberg, V, Darragh, T., & Smith-McCune, K. (2008). Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunology. https://doi.org/10.1038/mi.2008.33